571 related articles for article (PubMed ID: 32366588)
1. OpiA, a Type Six Secretion System Substrate, Localizes to the Cell Pole and Plays a Role in Bacterial Growth and Viability in
Cantlay S; Haggerty K; Horzempa J
J Bacteriol; 2020 Jun; 202(14):. PubMed ID: 32366588
[No Abstract] [Full Text] [Related]
2. PdpC, a secreted effector protein of the type six secretion system, is required for erythrocyte invasion by
Cantlay S; Kaftanic C; Horzempa J
Front Cell Infect Microbiol; 2022; 12():979693. PubMed ID: 36237421
[No Abstract] [Full Text] [Related]
3. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent
Jia Q; Horwitz MA
Front Cell Infect Microbiol; 2018; 8():154. PubMed ID: 29868510
[No Abstract] [Full Text] [Related]
4. A method for functional trans-complementation of intracellular Francisella tularensis.
Steele S; Taft-Benz S; Kawula T
PLoS One; 2014; 9(2):e88194. PubMed ID: 24505427
[TBL] [Abstract][Full Text] [Related]
5. Contributions of TolC Orthologs to
Kopping EJ; Doyle CR; Sampath V; Thanassi DG
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30670554
[No Abstract] [Full Text] [Related]
6. Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity.
Okan NA; Chalabaev S; Kim TH; Fink A; Ross RA; Kasper DL
mBio; 2013 Feb; 4(1):e00638-12. PubMed ID: 23404403
[TBL] [Abstract][Full Text] [Related]
7. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.
Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC
Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631
[TBL] [Abstract][Full Text] [Related]
8. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
[TBL] [Abstract][Full Text] [Related]
9. Francisella tularensis live vaccine strain folate metabolism and pseudouridine synthase gene mutants modulate macrophage caspase-1 activation.
Ulland TK; Janowski AM; Buchan BW; Faron M; Cassel SL; Jones BD; Sutterwala FS
Infect Immun; 2013 Jan; 81(1):201-8. PubMed ID: 23115038
[TBL] [Abstract][Full Text] [Related]
10. A Francisella tularensis locus required for spermine responsiveness is necessary for virulence.
Russo BC; Horzempa J; O'Dee DM; Schmitt DM; Brown MJ; Carlson PE; Xavier RJ; Nau GJ
Infect Immun; 2011 Sep; 79(9):3665-76. PubMed ID: 21670171
[TBL] [Abstract][Full Text] [Related]
11. Francisella tularensis IglG Belongs to a Novel Family of PAAR-Like T6SS Proteins and Harbors a Unique N-terminal Extension Required for Virulence.
Rigard M; Bröms JE; Mosnier A; Hologne M; Martin A; Lindgren L; Punginelli C; Lays C; Walker O; Charbit A; Telouk P; Conlan W; Terradot L; Sjöstedt A; Henry T
PLoS Pathog; 2016 Sep; 12(9):e1005821. PubMed ID: 27602570
[TBL] [Abstract][Full Text] [Related]
12. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.
Jia Q; Lee BY; Bowen R; Dillon BJ; Som SM; Horwitz MA
Infect Immun; 2010 Oct; 78(10):4341-55. PubMed ID: 20643859
[TBL] [Abstract][Full Text] [Related]
13. Deletion of the Major Facilitator Superfamily Transporter
Balzano PM; Cunningham AL; Grassel C; Barry EM
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29311235
[No Abstract] [Full Text] [Related]
14. Type VI Secretion System and Its Effectors PdpC, PdpD, and OpiA Contribute to
Brodmann M; Schnider ST; Basler M
Infect Immun; 2021 Jun; 89(7):e0057920. PubMed ID: 33875476
[TBL] [Abstract][Full Text] [Related]
15. Characterization of stable, constitutively expressed, chromosomal green and red fluorescent transcriptional fusions in the select agent bacterium, Francisella tularensis Schu S4 and the surrogate type B live vaccine strain (LVS).
Su S; Saldanha R; Pemberton A; Bangar H; Kawamoto SA; Aronow B; Hassett DJ; Lamkin TJ
Appl Microbiol Biotechnol; 2013 Oct; 97(20):9029-41. PubMed ID: 23852642
[TBL] [Abstract][Full Text] [Related]
16. ClpB mutants of Francisella tularensis subspecies holarctica and tularensis are defective for type VI secretion and intracellular replication.
Alam A; Golovliov I; Javed E; Sjöstedt A
Sci Rep; 2018 Jul; 8(1):11324. PubMed ID: 30054549
[TBL] [Abstract][Full Text] [Related]
17. Perforin- and granzyme-mediated cytotoxic effector functions are essential for protection against Francisella tularensis following vaccination by the defined F. tularensis subsp. novicida ΔfopC vaccine strain.
Sanapala S; Yu JJ; Murthy AK; Li W; Guentzel MN; Chambers JP; Klose KE; Arulanandam BP
Infect Immun; 2012 Jun; 80(6):2177-85. PubMed ID: 22493083
[TBL] [Abstract][Full Text] [Related]
18. EmrA1 membrane fusion protein of Francisella tularensis LVS is required for resistance to oxidative stress, intramacrophage survival and virulence in mice.
Ma Z; Banik S; Rane H; Mora VT; Rabadi SM; Doyle CR; Thanassi DG; Bakshi CS; Malik M
Mol Microbiol; 2014 Mar; 91(5):976-95. PubMed ID: 24397487
[TBL] [Abstract][Full Text] [Related]
19. Impact of Francisella tularensis pilin homologs on pilus formation and virulence.
Ark NM; Mann BJ
Microb Pathog; 2011 Sep; 51(3):110-20. PubMed ID: 21605655
[TBL] [Abstract][Full Text] [Related]
20. RipA, a cytoplasmic membrane protein conserved among Francisella species, is required for intracellular survival.
Fuller JR; Craven RR; Hall JD; Kijek TM; Taft-Benz S; Kawula TH
Infect Immun; 2008 Nov; 76(11):4934-43. PubMed ID: 18765722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
